[1] |
Hay ID, Thompson GB, Grant CS, et al. Papillary thyroid c a r c i n o m a m a n a g e d a t t h e M a y o C l i n i c d u r i n g s i x decades(1940-1999):temporal trends in initial therapy and longterm outcome in 2444 consecutively treated patients[J].World J Surg,2002,26(8):879-85.
|
[2] |
Wada N,Duh QY,Sugino K,et al. Lymph node metastasis from 25 9 papillary thyroid microcarcinomas: frequency, pattern of occurrence and recurrence, and optimal strategy for neck dissection[J]. Ann Surg,2003,237(3):399-407.
|
[3] |
American Thyroid Association (ATA) Guidelines Taskforce on Thyroid Nodules and Differentiated Thyroid Cancer, Cooper DS, Doherty GM, et al. Revised American thyroid association management guidelines for patients with thyroid nodules and differentiated thyroid cancer[J]. Thyroid,2009,19(11):1167-214.
|
[4] |
NCCN.org. NCCN Clinical Practice Guidelines in Oncology[S]. Thyroid carcinoma. Version 1.2012.http://www.nccn.org/ professionals/physician_gls/pdf/thyroid.pdf.
|
[5] |
Patron V, Bedfert C, Le Clech G, et al. Pattern of lateral neck metastases in NO papillary thyroid carcinoma[J].BMC Cancer,2011,11:8.
|
[6] |
Vergez S, Sarini J, Percodani J, et al. Lymph node management in clinically node-negative patients with papillary thyroid carcinoma[J].Eur J Surg Oncol,2010,36(8):777-82.
|
[7] |
Yan DG, Zhang B.cN0 papillary thyroid carcinoma in patients with cervical lymph node processing[J]. Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi,2012,47(3):257-60.[鄢丹桂,张彬.甲状腺 乳头状癌临床N0患者颈部淋巴结处理[J].中华耳鼻咽喉头颈外 科杂志,2012,47(3):257-60.]
|
[8] |
Wang SY,Zhu ZZ,Peng DF. et al. A clinic study of cervical lymph node matastasis in well-differentiated thyroid carcinoma[J]. Zhonghua Wai Ke Za Zhi, 2008,46(18):1404-6.[王圣应,朱正志, 彭德峰,等.分化型甲状腺癌颈淋巴结转移规律的研究[J].中华 外科杂志,2008,46(18):1404-6.]
|
[9] |
Zhang M,Wei T,Li ZH, et al. Related factors of central lymph node matastasis in papillary thyroid carcinoma[J]. Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi, 2012,47(7):565-70.[张明,魏涛,李 志辉,等.甲状腺乳头状癌中央区淋巴转移相关影响因素研究 [J] 中华耳鼻咽喉头颈外科杂志,2012,47(7):565-70.]
|
[10] |
Nixon IJ,Shaha AR. Management of regional nodes in thyroid cancer[J]. Oral Oncol,2013,49(7):671-5.
|
[11] |
Meng C,Gao J,Liang J, et al.Invasive properties of papillary thyroid cancer with concurrent BRAFV600E mutation and rearranged during transfection proto-oncogene protein expression[J]. Zhongguo Yi Xue Ke Xue Yuan Xue Bao, 2013, 35 (1):64-8.[孟超,高洁,梁军,等.甲状腺乳头状癌并BRAFV600E 突变及原癌基因重排蛋白表达与其侵袭性的关系[J].中国医学 科学院学报,2013,35(1):64-8.]
|
[12] |
Zhang YH,Wang GQ. Relationship of autophagy-related gene PTEN and Beclinl in papillary thyroid carcinoma[J]. Lin Chuang He Li Yong Yao Za Zhi, 2011,4(4):34-5.[张艳红,王桂琴.自噬相 关基因PTEN和Beclinl在乳头状甲状腺癌中的表达和意义[J]. 临床合理用药杂志,2011,4(4):34-5.]
|
[13] |
Wang JR, Li XH, Gao XJ,et al.Expression of MMP-13 is associated with invasion and metastasis of papillary thyroid carcin oma[J].Eur Rev Med Pharmacol Sci,2013,17(4):427-35.
|
[14] |
Wu WL,Fan LG,Wang OC, et al. Correlation between the lymph drainage of upperpole and lowerpole of thyroid and the central region lymph node[J]. Zhongguo Xian Dai Yi Sheng,2012,50(14): 12 9-30,132. [吴伟力,范丽妫,王瓯晨,等.甲状腺上下极淋巴引流 与中央区淋巴结相关性研究[J].中国现代医生,2012,50(14):129 -30,132.]
|
[15] |
Shaha AR.Central compartment dissection for papillary thyroid cancer[J].Br J Surg,2013,100(4):438-9.
|
[16] |
Sun RH, Li C, Fan JC, et al. Comparison of recurrence and complication by different thyroidectomy in the treatment of differentiated thyroid carcinoma as initial treatment:A metaanalysis[ J] Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi, 20 13,48(10):834-9.[孙荣昊,李超,樊晋川,等.不同术式初治分化 型甲状腺癌复发率及并发症比较的Meta分析[J].中华耳鼻咽喉 头颈外科杂志,2013,48(10):834-9.]
|
[17] |
Sun RH, Li C, Fan JC, et al. Meta-analysis of the clinical significance of thyroidectomy combined with central neck dissection in differentiated thyroid carcinoma at the first treatment[J]. Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi,2014,49(2):157-4.[孙荣昊,李超,樊晋川,等. 中央区淋巴清扫 术对初治分化型甲状腺癌临床价值的Meta分析[J].中华耳鼻咽 喉头颈外科杂志,2014,49(2):157-4.]
|